Vigil Neuroscience to Present at Upcoming Investor Conferences
Vigil Neuroscience, Inc. (NASDAQ: VIGL) had its price target raised by analysts at Wedbush from $23.00 to $24.00. They now have an "outperform" rating on the stock.
Vigil Neuroscience, Inc. (NASDAQ:VIGL) has caught the attention of institutional investors who hold a sizeable 41% stake [Yahoo! Finance]
Vigil Neuroscience Reports Third Quarter 2024 Financial Results and Provides Business Update
Vigil Neuroscience to Present at Guggenheim Healthcare Innovation Conference